| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.38B | 46.52B | 38.92B | 36.83B | 39.10B | 37.51B |
| Gross Profit | 13.48B | 14.95B | 13.24B | 12.17B | 11.82B | 11.91B |
| EBITDA | 8.05B | 8.66B | 7.75B | 7.09B | 6.61B | 6.99B |
| Net Income | 5.27B | 10.32B | 4.83B | 3.73B | 3.74B | 4.24B |
Balance Sheet | ||||||
| Total Assets | 49.71B | 66.03B | 51.87B | 52.02B | 49.84B | 47.42B |
| Cash, Cash Equivalents and Short-Term Investments | 16.77B | 18.01B | 17.32B | 13.92B | 11.02B | 12.91B |
| Total Debt | 3.81B | 5.99B | 3.91B | 4.76B | 5.31B | 4.06B |
| Total Liabilities | 14.52B | 21.60B | 15.33B | 18.17B | 18.26B | 18.22B |
| Stockholders Equity | 35.19B | 44.43B | 36.53B | 33.86B | 31.58B | 29.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.41B | 5.32B | 4.49B | 2.45B | 3.43B |
| Operating Cash Flow | 0.00 | 5.35B | 6.38B | 5.59B | 3.86B | 5.00B |
| Investing Cash Flow | 0.00 | -3.15B | 215.16M | -526.25M | -2.94B | -1.14B |
| Financing Cash Flow | 0.00 | -1.53B | -3.19B | -2.15B | -2.07B | -2.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥25.45B | 12.98 | ― | 5.04% | 0.95% | -5.24% | |
66 Neutral | ¥82.54B | 7.49 | ― | 2.30% | 19.53% | 117.58% | |
66 Neutral | ¥167.86B | 15.49 | 6.98% | 3.13% | 1.92% | 27.95% | |
65 Neutral | ¥483.93B | 19.88 | 7.93% | 2.32% | 0.24% | -54.29% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | ¥18.52B | 25.95 | ― | 3.24% | -6.49% | ― |